|
 |
 |
 |
 |
|
A 36-year-old man with a red eye
Digital Journal of Ophthalmology 2008 Volume 14, Number 9 April 13, 2008
|
Printer Friendly
|
|
|
|
References | 1. Opremcak EM. Uveitis. New York: Springer-Verlag, 1995.
2. Boyd SR, Young S, Lightman S. Immunopathology of the Noninfectious Posterior and Intermediate Uveitides. Survey of Ophthalmology. 2001; 46(3): 209-233.
3. Kilmartin DJ, Dick AD, Forrester JV. Prospective Surveillance of Sympathetic Ophthalmia in the UK and Republic of Ireland. British Journal of Ophthalmology. 2000; 84: 259-263.
4. D’Amico FM, Kiss S, Young LH. Sympathetic Ophthalmia. Seminars in Ophthalmology. 2005; 20(3): 191-197.
5. Chu D, Foster CS. Sympathetic Ophthalmia. International Ophthalmology Clinics. 2002; 42(3): 179-185.
6. Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the Use of mmunosuppressive Drugs in Patients with Ocular Inflammatory isorders. American Journal of Ophthalmology. 2000; 130(4): 492-513.
7. Okada AA. Immunomodulatory Therapy for Ocular Inflammatory Disease. Ocular Immunology and Inflammation. 2005; 13:335-351. | |
|
 |
 |
 |

|
|